Emerging therapies in anaphylaxis: alternatives to intramuscular administration of epinephrine

B Boswell, SA Rudders, JC Brown - Current Allergy and Asthma Reports, 2021 - Springer
Abstract Purpose of Review Anaphylaxis is a severe, life-threatening, systemic allergic
reaction that should be recognized and treated promptly. Intramuscular (IM) epinephrine is …

[HTML][HTML] Innovations in the treatment of anaphylaxis: a review of recent data

JA Lieberman, J Oppenheimer… - Annals of Allergy …, 2023 - Elsevier
Abstract Purpose of Review The current standard of first-line emergency treatment of
anaphylaxis is intramuscular (IM) epinephrine, mostly administered through epinephrine …

Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails

AM Kemp, SF Kemp - Current Opinion in Allergy and Clinical …, 2014 - journals.lww.com
Some anaphylactic reactions are so severe that treatment is unsuccessful despite rapid
recognition and treatment. Improving the evidence base for the various treatment modalities …

Epinephrine in the Management of Anaphylaxis

JC Brown, E Simons, SA Rudders - The Journal of Allergy and Clinical …, 2020 - Elsevier
Epinephrine is life-saving and the only first-line medication in the management of
anaphylaxis. At therapeutic doses, it acts rapidly to reverse nearly all symptoms of …

A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector

DA Dworaczyk, AL Hunt, M Di Spirito, M Lor… - Journal of Allergy and …, 2024 - Elsevier
Background Recent acute anaphylaxis guideline updates have identified remaining unmet
needs based on currently available therapeutic options as a critical focus. Objective We …

Epinephrine and its use in anaphylaxis: current issues

KJ Simons, FER Simons - Current opinion in allergy and clinical …, 2010 - journals.lww.com
Epinephrine is the medication of choice in the first-aid treatment of anaphylaxis in the
community. For ethical reasons, it is not possible to conduct randomized, placebo-controlled …

International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals

S Dreborg, G Walter, H Kim - Allergy, Asthma & Clinical Immunology, 2022 - Springer
Background In anaphylaxis, the dosing of injectable epinephrine in medical settings has
been arbitrarily recommended to be 0.01 mg/kg of body weight. For ethical reasons, there …

Advancements in Anaphylaxis Management

A Alvarez-Perea, P Cabrera-Freitag… - Current …, 2023 - ingentaconnect.com
Anaphylaxis is defined as a severe life-threatening, generalized or systemic hypersensitivity
reaction. Yet, anaphylaxis is often difficult to diagnose, leading to a delay in applying …

[HTML][HTML] Epinephrine: the drug of choice for anaphylaxis--a statement of the World Allergy Organization

SF Kemp, RF Lockey, FER Simons… - World Allergy …, 2008 - Elsevier
Anaphylaxis is an acute and potentially lethal multisystem allergic reaction. Most consensus
guidelines for the past 30 years have held that epinephrine is the drug of choice and the first …

[HTML][HTML] Who needs epinephrine? Anaphylaxis, autoinjectors, and parachutes

TE Dribin, S Waserman, PJ Turner - The Journal of Allergy and Clinical …, 2023 - Elsevier
International guidelines stipulate that intramuscular (IM) epinephrine (adrenaline) is the first-
line treatment for anaphylaxis, with an established good safety profile. The availability of …